Details for New Drug Application (NDA): 019429
✉ Email this page to a colleague
NDA 019429 describes FIORINAL W/CODEINE, which is a drug marketed by Allergan and is included in one NDA. Additional details are available on the FIORINAL W/CODEINE profile page.
The generic ingredient in FIORINAL W/CODEINE is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.
The generic ingredient in FIORINAL W/CODEINE is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.
Summary for 019429
| Tradename: | FIORINAL W/CODEINE |
| Applicant: | Allergan |
| Ingredient: | aspirin; butalbital; caffeine; codeine phosphate |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG;30MG | ||||
| Approval Date: | Oct 26, 1990 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
